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ABSTRACT 
Purpose 
To quantify the extent of lipid rich necrotic core (LRNC) and intraplaque hemorrhage (IPH) in 
atherosclerotic plaques.  
Methods 
Patients scheduled for carotid endarterectomy underwent four-point Dixon and T1-weighted 
magnetic resonance imaging (MRI) at 3T. Fat and R2* maps were generated from the Dixon 
sequence at the acquired spatial resolution of 0.60 x 0.60 x 0.70 mm voxel size. MRI and 3D 
histology volumes of the plaques were registered. The registration matrix was applied to 
segmentations denoting LRNC and IPH in 3D histology to split plaque volumes in regions with 
and without LRNC and IPH. 
Results 
Five patients were included. Regarding volumes of LRNC identified by 3D histology, the 
average fat fraction by MRI was significantly higher inside LRNC than outside: 12.64±0.2737 % 
versus 9.294±0.1762 % (mean±SEM, P<0.001). The same was true for IPH identified by 3D 
histology, R2* inside versus outside IPH was: 71.81±1.276 s-1 versus 56.94±0.9095 s-1 
(mean±SEM, P<0.001). There was a strong correlation between the cumulative fat fraction by 
MRI and the volume of LRNC from 3D histology (R2=0.92) as well as between cumulative R2* 
and IPH (R2=0.94).  
Conclusion 
Quantitative mapping of fat and R2* from Dixon MRI reliably quantifies the extent of LRNC 
and IPH. 
Key Words: magnetic resonance imaging; quantitative mapping; atherosclerosis; carotid artery. 
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INTRODUCTION 
Decisions to intervene in atherosclerotic cardiovascular disease (CVD) are primarily based on 
stenosis severity. For example, patient selection for carotid endarterectomy (CEA) relies on the 
presence of symptoms indicative of cerebral ischemia and the degree of luminal narrowing 
caused by the carotid plaque (1). However, there is increasing evidence that stenosis severity 
alone is not sufficient to determine stroke risk. It has been shown that patients at high risk for 
stroke, but without any measurable stenosis, have a high proportion of advanced plaques (2). 
Furthermore, there is evidence that carotid plaque composition per se is a predictor of 
cardiovascular events (3). Thus, assessing carotid plaque composition non-invasively would 
arguably improve risk assessment for cardiovascular events, not only for stroke, but throughout 
the entire arterial circulation. 
Plaques at high risk for causing arterial thrombosis with subsequent ischemic necrosis are 
called vulnerable plaques. Arterial thrombosis is most often caused by rupture or erosion of a 
vulnerable plaque (4).  Established features of vulnerable plaques are lipid-rich necrotic core 
(LRNC), intraplaque hemorrhage (IPH), thin fibrous cap and, to a lesser extent, plaque 
calcification (4). Owing to its excellent soft tissue sensitivity, magnetic resonance imaging 
(MRI) has been used for carotid plaque characterization by multiple groups. Typically, blood 
suppressed T1-weighted (T1W), T2-weighted (T2W), proton density-weighted (PDW) fast spin 
echo, gradient echo and time of flight sequences are used (5). Using this multi-contrast approach, 
different plaque components can be identified, based on their relative signal intensity compared 
to the signal intensity of surrounding muscle, typically the sternocleidomastoid (6). Multi-
contrast MRI has been successfully used to characterize carotid plaques, it has been validated by 
histology in a number of studies (5) and it offers stroke risk information beyond measurement of 
luminal narrowing in carotid atherosclerosis (7). 
Despite these advantages, there are limitations to multi-contrast MRI of carotid plaque that 
prevent its wide-spread clinical application. One of these is that it relies on extensive post-
acquisition assessment of differences in image intensity. The non-quantitative nature of this 
assessment, its operator dependency, its reliance on multiple sequences and the fact that the 
sequences are not entirely specific for the plaque components of interest, present barriers to the 
adoption of multi-contrast MRI in routine clinical practice. As mentioned above, for carotid 
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plaque imaging the sternocleidomastoid muscle is used as reference tissue. However, when the 
signal intensity form the adjacent muscle on fat- suppressed T2W images is too low for use as a 
standard reference, the submandibular and parotid glands have been used (8). Ideally the 
reference tissue should represent a uniform distribution of intensity values, independent of its 
location within the image volume but in reality this is rarely the case. One of the biggest sources 
of intensity inhomogeneity is the surface coil used in carotid imaging and numerous approaches 
have been proposed to correct this problem (9). For example, all manufacturers use coil 
sensitivity maps acquired in separate reference scans to correct for intensity inhomogeneity, but 
because these maps only rescale to the homogeneity of integrated body coil, they do not 
necessarily provide a truly uniform homogeneity. Because of its proximity to the skin, intensity 
in images acquired from the sternocleidomastoid muscle is especially sensitive to the 
inhomogeneity caused by the sensitivity profile of surface coils. Thus, the issues with assessing 
plaque components based on relative image intensity emphasize the need for quantitative 
physical measurements of plaque constituents associated with vulnerability. 
Regarding the validation of carotid plaque MRI, histology is the gold standard to determine 
plaque composition. Hence validation of in vivo MRI is possible by mapping histological data to 
in vivo data. Most often histology sections of the plaque are registered to in vivo images using the 
carotid bifurcation as a landmark (10). Due to the difference in MRI slice thickness (mm) and the 
thickness of histology sections (µm), there is a risk of inaccurate registration, even when using 
an easily recognizable landmark such as the carotid bifurcation. This problem increases with 
increasing distance from the bifurcation. The need for accurate registration of MRI and histology 
is further emphasized by the fact that there is significant variation in plaque composition along 
the length of the plaque (11). Adding to the complexity of registering 2D histology sections with 
MRI slices is the fact that out-of-plane angulations of the histology sections versus the MRI 
slices, as well as shrinkage and deformation during tissue processing are routinely neglected 
(12). 
The goal of the current study was to develop a quantitative fat and R2* mapping technique 
to provide quantitative in vivo measurements of the extent of LRNC and IPH in carotid plaque. 
To this end we used a four-point Dixon gradient-echo sequence to measure LRNC and extracted 
the R2* value to quantify IPH. Originally proposed by Dixon (13), this gradient-echo sequence 
takes advantage of the slightly different resonance frequency of fat and water, which leads to 
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constructive and destructive interference of signal when measuring at different echo times. 
Analysis of the resulting signal oscillations allows for the calculation of the quantity of both 
water and fat in the human body (13). Simultaneously, signal is lost due to phase dispersion (the 
transverse T2* relaxation), which is increased by local magnetic field disturbances, for example 
due to the presence of iron. Therefore the rate of signal loss (R2* = 1/T2*) in a carotid plaque 
can be viewed as a measure for the presence of (heme) iron and thus can be expected to correlate 
to the extent of IPH. Indeed, in a different context, i.e. MRI of the brain R2* has been shown to 
correlate strongly and in a linear fashion with tissue iron content (14). Additionally, to overcome 
the shortcomings related to validation of in vivo MRI with 2D histology, we validated the MRI-
based quantification of LRNC and IPH by correlating the measurements with registered 3D 
histology volumes of the plaques. A preliminary version of the current data was presented in 
poster format at the American Heart Association’s Annual Scientific Sessions 2014 (15). 
METHODS 
The study was approved by Linköping’s Institutional Review Board (record no.:  2012/321-32) 
and written informed consent was obtained from all participants prior to study entry. 
Patients 
Patients were included in the study if they were scheduled for CEA. The indication for CEA was 
the presence RIDKLJKJUDGHFDURWLGDUWHU\VWHQRVLVwith or without recent (< 14 days) 
cerebrovascular ischemia in the form of stroke, transient ischemic attack or amaurosis fugax. 
Stenosis severity was assessed by measuring peak systolic velocity from the Doppler signal 
acquired during ultrasound imaging of the carotid artery, according to criteria established in the 
European Carotid Surgery Trial (16). All patients underwent MRI < 24 hours before surgery.  
Magnetic Resonance Imaging 
We applied a four-point Dixon sequence at 3T to generate high resolution maps of the fat 
percentage and values of R2* relaxation rate per voxel in atherosclerotic plaque. At 3T the 3.3 
ppm frequency difference between water and fat creates an oscillating signal every 2.4 ms. Due 
to the limited gradient slew rate and strength needed to achieve sufficient resolution in the 
acquisition, we chose an out-of-phase, in-phase, out-of-phase, in-phase scheme, at echo times of 
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multiples of 3.6 ms (hence at TE = 3.6, 7.2, 10.8 and 14.4 ms). The water-fat-shift was 
maximized at 1.3 pixels. It was assumed that all voxels exhibited a single, effective R2* 
relaxation rate. Proton density and T1 relaxation differences between water and fat were not 
taken into account. Hence, the signal magnitude S at each echo time TE was modelled according 
to: ܵ(ܶܧ) = (ܹ + ܨܿ݋ݏ(2Sܶܧ/2.4))exp (െܴ2כܶܧ) 
where W is the water fraction and F is the fat fraction. The water and fat percentages were 
calculated by division by the sum of the two. Other acquisition parameters for the sequence were 
TR = 18 ms, TFE factor 12 and flip angle 10 degrees. The field of view was 220x220x60 mm, 
centered on the flow divider at an isotropic acquisition resolution 0.75 mm, reconstructed at 0.60 
mm. The acquisition used a Cartesian 3D read-out where k-space filling was performed from the 
center outwards (low-high, radial). The corners of k-space were not included, resulting in a 
cylindrical. Two regional saturation slabs of 80 mm were added inferior and superior to the 
acquisition volume, with a gap of 40 mm, to suppress inflowing blood signal. Using a TR = 18 
ms and TFE = 12 these saturation bands were applied every 216 ms. The scan time was 9:45 
minutes. Modelling and post-processing was performed in an adapted version of SyMRI 
software (SyntheticMR, Linköping, Sweden) producing fat, water and R2* maps at the acquired 
spatial resolution of 0.60 x 0.60 x 0.70 mm voxel size. The post-processing time was 10 seconds. 
In addition to the four-point Dixon acquisition a T1W TSE acquisition was performed with 
TE = 9 ms, TR = 1 heart-beat and TSE factor 6. A black-blood pulse sequence was used with a 
delay of 430 ms. The acquisition resolution was 0.55 mm, reconstructed at 0.47 mm; 18 slices of 
2.1 mm, no gap, were acquired. 
All scans were acquired on a 3T Philips Ingenia system using a 20 channel 
HeadNeckSpine coil (Philips Healthcare, Best, the Netherlands). 
3D Histology and Image Registration 
Figure 1 summarizes the tissue and image processing steps involved in the generation of the 3D 
histology volumes, image segmentation and registration. The plaques were fixed in 10% 
formalin immediately after surgery, decalcified, embedded in paraffin and trimmed at 50µm 
intervals. At every 50 µm step an image was taken of the plaque surface with the plaque 
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positioned vertically in the paraffin block. Thus, these so called en face images represent cross-
sectional views of the plaque. An example is shown in the upper bar of Figure 1, to the right 
hand side of  the caption “En face images from paraffin block”. These images were taken using a 
fluorescent microscope with a mechanical stage using a 5x objective, taking advantage of the 
autofluorescence of the tissue (Imager.Z1 AxioCam MRm, Carl Zeiss, Jena, Germany). At every 
200 µm step, a 5 µm thick section was taken for morphometric assessment of LRNC and IPH. 
Areas containing amorphous material and cholesterol crystals were classified as LRNC. The 
sections were stained trichrome to detect red blood cells and areas containing red blood cells 
were classified as IPH. Whole slide digital imaging of the stained sections was performed with 
brightfield microscopy using a 10x objective (Imager.Z1 AxioCam ERc 5s, Carl Zeiss, Jena, 
Germany).   
The en face images were used to generate the 3D backbone for subsequent registration 
with the histology sections. To this end they were automatically registered to form a digital 
image stack using the StackReg plugin (17) within ImageJ 1.49 (National Institutes of Health, 
Bethesda, MD, USA). This image stack was loaded into ITK-SNAP 2.2 (Penn Image Computing 
and Science Laboratory (PICSL), University of Pennsylvania, Philadelphia, PA, USA), to 
automatically create a segmented volume using a sparse field level set segmentation method 
(18,19). Next, the stained histology sections were manually registered to the corresponding en 
face image within ImageJ using the interactive affine plugin, thus correcting for any 
deformations that might have occurred during sectioning and transfer onto the glass slide. The 
tissue expands when sectioned and transferred to the glass slide and to quantify the extent of 
expansion, morphometric analysis was used in ImageJ, measuring the area of the en face image 
in the paraffin block and the area of its corresponding trichrome stained section on the slide. A 
stack of the histology sections was then generated, imported into ITK-SNAP and 3D volumes of 
the LRNC and IPH were generated by manual segmentation.  These volumes integrate the 
morphometric data on LRNC and IPH into the 3D backbone.  
The resultant volumes and MRI data were imported into MeVisLab 2.2.1 (MeVis Medical 
Solutions AG, Bremen, Germany) where the T1W MRI was automatically registered to the 
water, fat, and R2* maps from the four-point Dixon sequence using the MERIT framework 
within MeVisLab (20). The MRI data was up-sampled by a scale of 10 and the 3D histology 
volume was manually registered with the T1W MRI by matching the lumen in the 3D histology 
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volume with the lumen within the MRI throughout the volume (Fig. 4A). The fresh sample 
shrinks during the processing steps that precede paraffin embedding and shrinkage was 
accounted for by manually stretching the 3D volume to match the lumen in the T1W image thus 
achieving accurate registration of both volumes. To quantify the extent of shrinkage 
morphometric analysis was performed using ImageJ, comparing the area of the en face image 
with the area of the plaque on the cranial surface of the corresponding T1W image slice. In 
addition this registration step allowed for adjustment of the 3D histology volume to out-of-plane 
angulations in the MRI (Fig. 4B). The resultant registration matrix was then applied to the 
segmentations denoting LRNC and IPH from 3D histology to split the plaque volume in regions 
with and without LRNC and IPH. For each of the resulting volumes (whole plaque, areas within 
LRNC, IPH and areas outside LRNC and IPH), the fat and R2* values in each voxel were 
recorded.  
Statistical Analysis 
Statistical analysis was performed using GraphPad Prism (version 6.05, GraphPad Software, 
Inc., La Jolla, CA, USA). An unpaired t test was used to analyze the differences between average 
MRI values per voxel within LRNC and IPH as defined by 3D histology versus the MRI values 
outside LRNC and IPH. These values are presented as a mean ±SEM and P-values < 0.05 were 
considered statistically significant. Linear regression analysis was performed to study the 
relationship between the cumulative value of corresponding MRI measurements from each voxel 
throughout the plaque and the volume of LRNC and IPH from histology. To assess the mean 
difference between the MRI values and the corresponding histological data and the 95% limits of 
agreement between them, Bland-Altman plots were generated. To account for the fact that the 
difference between the methods increased as the magnitude of the measured values increased, the 
approximate proportionality between difference and magnitude of the measurements was 
addressed as recommended by Bland and Altman, by plotting the ratio of the MRI values versus 
the 3D histology values as a function of their average (21). 
RESULTS 
Patients 
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A total of eight patients consented to participate in the study. In one patient the MRI was of 
insufficient quality due to bulk motion artefacts due to swallowing and in one patient the scan 
had to be aborted because of claustrophobia. Furthermore, in one patient the plaque specimen 
was too fragmented to be able to generate a 3D histology volume. Thus, here we report on five 
patients with good quality MRI and intact plaque specimens. In four patients the stenosis was 
associated with recent cerebral ischemia and in one patient the stenosis was asymptomatic. The 
clinical characteristics, cardiovascular risk factors, co-morbidity and medication of these patients 
are summarized in Table 1 and 2.  
Registration of 3D Histology with Magnetic Resonance Imaging 
All plaques exhibited LRNC and IPH and therefore were all classified as advanced lesions 
ranking in category VI of the American Heart Association’s atherosclerotic lesion classification 
system (22). Registration of the histological sections to the 3D backbone showed that sectioning 
and positioning of the tissue on glass slides caused an expansion of the tissue by 15.4 ± 4.1 % 
(mean ± SD) relative to its dimensions in the paraffin block. The scaling factors used in 
registration of 3D histology to T1W MRI are shown in Supporting Table 1. This registration 
revealed that average shrinkage of the plaque was 9.2 ± 2.1 % (mean ± SD) relative to the 
situation in vivo. The out-of-plane angulations in each patient are shown in Figure 4B which 
shows that there are clear differences between the scanning direction in vivo and the vertical 
orientation of the tissue section in the paraffin block. 
Validation of Magnetic Resonance Imaging by 3D histology 
After registration with 3D histology and segmentation of LRNC and IPH volumes based on the 
histology volumes, we were able to generate fat and R2* maps from Dixon imaging that gave us 
the fat fraction and R2* value for each voxel inside and outside the LRNC and IPH (Figs. 5, 6). 
Figure 7 illustrates the fat fractions and the R2* values throughout each individual plaque. As is 
apparent from this data, the extent of LRNC and IPH varied considerably between plaques and the 
MRI measurements tracked this variability. Because of the large variation in the extent of LRNC 
and IPH between plaques, we chose to use the same length for x and y axes but to vary the scale 
on these axes to reflect the different sizes of LRNC and IPH among plaques. 
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 First, we compared the fat fractions and R2* values by MRI throughout all plaques inside 
and outside volumes of LRNC and IPH as identified by 3D histology. The average fat fraction by 
MRI was significantly higher inside LRNC than outside: 12.64±0.2737 % versus 9.294±0.1762 % 
(mean±SEM, P<0.001). The same was true for IPH identified by 3D histology, R2* was 
significantly higher inside IPH than outside: 71.81±1.276 s-1 versus 56.94±0.9095 s-1 (mean±SEM, 
P<0.001). As shown in Figure 6 these differences persisted at the same level of significance for 
each individual patient. 
 Next, we assessed the correlation between the cumulative fat fractions and R2* values from 
MRI and the volumes of LRNC and IPH from 3D histology. Taking together all values from all 
plaques, linear regression showed a strong correlation throughout all plaques between the 
cumulative fat fraction as measured in each voxel and the volume of LRNC from 3D histology 
(R2=0.92) as well as between the cumulative R2* per voxel and the volume of IPH (R2=0.94). 
These strong correlations were maintained at the level of the individual patient as shown in Figure 
7. Figure 8 shows the mean difference and 95% limits of agreement between MRI and 3D 
histology. The cumulative fat fraction as measured by Dixon MRI and the volume of the LRNC 
are shown in Figure 6 which shows that for each plaque, there was a strong positive correlation 
throughout the plaque between the cumulative fat fraction by MRI and the LRNC volume from 
3D histology. The correlation between cumulative R2* and the volume of IPH also showed strong 
positive correlations between these parameters for every plaque.  
DISCUSSION 
Here we show that plaque characteristics associated with a high risk of rupture and thrombosis, 
can be quantified in vivo at high resolution by MRI. Moreover, we use 3D histology to validate 
in vivo carotid MRI, thus increasing the reliability of histology based validation of in vivo 
vascular imaging. 
 Through registration of T1W MRI with a four point Dixon gradient-echo sequence, we 
were able to accurately map the fat fraction and the R2* value of each voxel to atherosclerotic 
plaques in the internal carotid artery. There was high variability among the plaques regarding the 
extent of LRNC and IPH and the fact that we show strong correlations between MRI and 3D 
histology in all plaques speaks to the robustness and wide applicability of this technique. 
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 As outlined earlier, a quantitative MRI method for the measurement of the extent of LRNC 
has not been available. Regarding IPH, others have assessed the extent of IPH using a T2
 
mapping technique (23). This technique was validated against multi contrast T1W, PDW and 
T2W carotid MRI but histological validation was not reported. Moreover, the T2 images were 
acquired using a spin-echo sequence, which precludes the acquisition of T2* and thus R2*. T2* 
relaxation is seen only with gradient-echo imaging because transverse relaxation caused by 
magnetic field inhomogeneities is eliminated by the 180° pulse at spin-echo imaging (24). 
Importantly, the R2* value has a strong, linear correlation with tissue iron content. Using 
chemically determined iron concentrations, Langkammer et al. demonstrated that transverse 
relaxation rates show a strong, linear correlation with tissue iron concentration throughout the 
brain but that in white matter structures, only R2* showed a linear correlation with iron 
concentration (14). Thus, we chose R2* for the quantification of the extent of IPH. More recently 
quantitative T1 and T2 mapping has been proposed for plaque characterization but these 
sequences were not validated against plaque histology thus it remains to be determined which 
plaque components are identified by this technique (25). 
 Others have indicated the need for the validation of in vivo imaging using 3D histology and 
it has been used to optimize registration of carotid plaque histology to carotid MRI and CT 
angiography in vivo (12,26). The improvements in registration offered by 3D histology come 
from its ability to account for tissue deformation during different tissue processing steps as well 
as the angulation differences between the specimen positioned vertically in a paraffin block and 
the in vivo image. The need to correct for tissue deformation is emphasized by the degree of 
expansion that we were able to calculate after the tissue sections had been registered to the 3D 
backbone generated from the en face images of the specimen. Furthermore, we were able to 
correct for shrinkage of the fresh specimen by registering the 3D volume to in vivo MRI, using 
the vessel lumen as a landmark. This was greatly facilitated by the black blood sequence 
acquired during T1W imaging, which, owing to its high signal to noise ratio, allowed for accurate 
delineation of the vessel lumen. Moreover, the ability of 3D histology to support correction of 
the registration errors caused by angulation differences between the paraffin embedded specimen 
plaque and in vivo MRI is illustrated by the fact that a small angulation error of 7° already results 
in a longitudinal displacement error of 0.6 mm (1 voxel) at a distance of 5 mm (12). The 
difficulties encountered in registration of 2D histology with 2D MRI slices are illustrated in 
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Figure 5 where we show that there is partial mismatch between 2D histology and 2D MRI 
because the difference in angulation between histology sections and MRI cannot be taken into 
account upon registration of 2D images. Importantly, here, we advance the utility of 3D 
histology beyond its ability to optimize registration by generating 3D volumes from the stack 
that include volumes relevant to the assessment of atherosclerotic plaque vulnerability, i.e. the 
volumes of LRNC and IPH. This enabled us to add a quantitative dimension to the improved 
registration offered by 3D histology by comparing the voxel-wise measurement of fat and R2* to 
the volume of LRNC and IPH upon 3D histology. 
Multi-contrast MRI of carotid plaque has been used as a tool to assess stroke risk (7). 
However, to date it has been difficult to connect MRI biomarkers of carotid plaque vulnerability 
with the patho-biology of stroke and atherosclerotic plaque progression. There are numerous 
reasons for this lack of agreement between MRI and cerebrovascular ischemia as well as carotid 
plaque pathobiology. It cannot be ruled out however, that the lack of specificity for LRNC and 
IPH of the sequences currently used in multi-contrast plaque MRI, the non-quantitative nature of 
the approach and its operator dependency have a detrimental effect on accuracy and 
reproducibility in longitudinal studies. This, in turn, may impact the analysis of the relationship 
between patho-biology and imaging biomarkers of plaque instability. Here, we present a single 
sequence that allows for direct in vivo quantitative, automated mapping of LRNC and IPH in 
carotid plaque. Importantly, the method correlates closely with the extent of LRNC and IPH in 
3D histology over a wide range of volumes of LRNC and IPH. Due to its quantitative nature, this 
approach may be able to improve estimation of stroke- and overall cardiovascular risk and 
elucidate the relationship between patho-biology and imaging biomarkers of plaque instability. 
Moreover, because of its relative simplicity and its use of automated voxel based quantification 
of LRNC and IPH it may prove to be particularly well suited for application in longitudinal 
studies.   
A limitation inherent to the four-point Dixon method is its coarse modelling, where R2* 
differences, proton density differences and T1 relaxation differences between water and fat are 
ignored. Moreover, the fat frequency peak is known to consist of multiple components, with a 
broad width, leading to an effective increased relaxation rate. These model assumptions were 
made since adding more degrees of freedom to the analysis would not be valid for a four-point 
measurement. Our goal was to develop a sequence that would be practical in routine patient care, 
12 
 
thus a (relatively) short scan time and good repeatability for follow-up studies were important 
requirements. Therefore, we accepted a potential statistical offset for the water and fat fractions 
and other limitations inherent in the short scan time. Another limitation of our Dixon method is 
the T1-weighting due to the acquisition settings (TR = 18 ms, flip = 10 degrees). T1-weighting 
will suppress the water compartment more than the fat compartment, leading to an artificial 
enhancement of the fat content. This choice was made due to constraints regarding scan time and 
the signal to noise ratio (SNR). If the T1-weighting were to be limited to < 10% for both 
compartments a TR > 130 ms would be required, corresponding to a 7-fold increase in scan time. 
Since the exact T1-relaxation is unknown, no attempt was made to correct for this effect. It is 
therefore reasonable to assume that the T1 weighting in the current protocol will contribute to an 
overestimation of the fat content. An additional, related effect is the B1 inhomogeneity, which 
may cause differences in T1-weighting throughout the volume. This effect however, is expected 
to be small considering the size of the acquisition volume and the moderate effect of B1 
differences on saturation differences. Furthermore, the additional signal loss due to susceptibility 
differences over the imaging volume was ignored, potentially leading to an underestimation of 
R2*. However, in view of the very high R2* values found in hemorrhagic plaques with rates of 
over 50 s-1, the effect of susceptibility is expected to be negligible.  
Regarding registration of 3D histology with MRI, it is to be expected that the strong 
correlations reported here between MRI based quantification of LRNC and IPH and 3D 
histology would be strengthened further if methods for non-rigid registration of MRI and 3D 
histology volumes had been available during the study. As expected there are slight differences 
in the slopes of the regression lines shown in Figure 7. In other words there is a strong 
correlation between the volume of LRNC and IPH and fat and R2* by MRI within each patient 
but there are differences between individual patients. This speaks to the strong heterogeneity in 
the composition of atherosclerotic plaques in general and the differences between patients in the 
current study. Even within areas designated as LRNC and IPH by their histological appearance, 
the tissue is heterogeneous (Fig. 3) and the fat and R2* values in one voxel may differ from 
those in adjacent voxels. Furthermore, there are sources of fat and blood outside the LRNC and 
IPH, in the form of lipid laden macrophage foam cells and capillaries that are filled with blood 
(3). We would submit however, that the strong correlations between 3D histology and MRI 
found for every patient speaks to the robustness of the MRI technique and that adequately 
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powered prospective studies will help establish threshold fat and R2* values that predict carotid 
plaque rupture and ischemic cerebral events.  
Finally, image artifacts due to patient motion constitute a major issue in carotid MRI and 
around 15% of all carotid MRI scans have unacceptable image quality (27). In the current study 
the MRI quality was not compromised by motion artifacts in six out of seven patients in whom 
we were able to acquire MRI, thus our fail rate due to motion artifact is within the 15% reported 
by others. However, we acknowledge that our high-resolution Dixon sequence, scanned without 
a dedicated carotid coil has a relatively low SNR. In future studies we anticipate that the use of a 
dedicated carotid coil will increase the SNR and reduce the fail rate. Unfortunately, we did not 
have access to such a coil during the present study. The increased SNR could allow for 
reductions in scan time via the use of higher parallel imaging factors. In view of the long scan 
time and the small voxel size in the current imaging protocol, we would not use additional SNR 
to reduce voxel size. Furthermore, the present study did not use motion rejection techniques. Our 
3D acquisition is relatively insensitive to pulsatile motion since the k-space read-out occurs in a 
radial low-high fashion. If a number of k-space lines display a different signal intensity due to 
blood flow for example the effect will, after Fourier Transform, be spread out as radial streaking 
artifacts over the entire image, and not, as in the linear Cartesian case as a band centered at the 
vessel. Bulk motion, however, disrupts the imaging, as exemplified in the one case that was 
excluded. Techniques that reject data acquired during swallowing such as free-induction decay 
navigators could be applied in the future to reduce the fail rate (28).   
 
CONCLUSIONS 
In conclusion, we present a quantitative mapping technique for atherosclerotic LRNC and IPH 
which relies on direct measurement of fat and iron sensitive imaging. Moreover, we have 
validated this technique thoroughly using 3D histology. The quantitative nature of this technique 
should facilitate the interrogation of the relationship between MRI biomarkers of carotid plaque 
vulnerability, atherosclerotic plaque progression and stroke from carotid plaque. Its reliance on a 
single sequence and the automated nature of the quantification should facilitate transferability 
between scanners and assessment of changes in LRNC and IPH in longitudinal studies. 
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SUPPORTING INFORMATION 
Supporting Table 1. Scaling Factors Applied upon Registration of 3D Histology with 
Magnetic Resonance Imaging.  
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TABLES 
Table 1. Baseline Characteristics 
  Patient 1  Patient 2  Patient 3  Patient 4  Patient 5 
Gender  male  female  female  male  male 
Age (years)  64  75  79  66  90 
Location of endarterectomy  right  left  left  right  left 
>ŽĐĂƚŝŽŶŽĨш ? ?йƐƚĞŶŽƐŝƐ  right  left  left  right  left 
Symptomatic stenosis  yes  yes  yes  no  yes 
Peak systolic flow velocity (m/sec.)  3.2  2.5  6.5  2.5  4.6 
Stenosis severity  80- ? ?й  70- ? ?й  80- ? ?й  70- ? ?й  80- ? ?й 
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Table 2. Cardiovascular Risk Factors, Co-Morbidity and Medication at Baseline 
  Patient 1  Patient 2  Patient 3  Patient 4  Patient 5 
Hypertension  yes  yes  yes  yes  yes 
Body mass index (kg/m2)  27  39  35  32  26 
Total cholesterol (mmol/L)  3.3  4.4  4.6  3.0  4.8 
LDL cholesterol (mmol/L)  1.2  2.3  2.8  1.2  n.a. 
HDL cholesterol (mmol/L)  1.1  1.2  1.1  1.0  0.69 
Triglycerides (mmol/L)  2.2  2.1  1.5  1.9  5.8 
Diabetes mellitus  no  no  yes  yes  no 
GFR (mL/min.)  112  94  54  72  65 
Chronic kidney disease stage  1  1  1  1  2 
Current smoker  yes  no  yes  no  no 
Former smoker    no    yes  yes 
Alcohol abuse  no  no  no  no  no 
Other cardiovascular disease           
Ischemic heart disease  no  no  no  yes  yes 
Lower extremity disease  no  no  yes  no  no 
Atrial fibrillation  no  no  no  no  no 
Heart failure  no  no  no  no  no 
Medication           
Statin  yes  yes  yes  yes  yes 
Platelet inhibitor  yes  yes  yes  yes  yes 
Anti-coagulant  no  no  no  no  no 
Anti-hypertensive  yes  yes  yes  yes  yes 
 
GFR – glomerular filtration rate; HDL – high density lipoprotein; LDL – low density lipoprotein. 
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FIGURE LEGENDS 
Figure 1. Segmentation and registration steps in 3D histology and registration with T1-weighted 
magnetic resonance imaging. 
 
Workflow outlining the steps involved and the software that was used in generating 3D histology 
volumes from carotid plaques obtained after carotid endarterectomy surgery. These volumes 
contain the volumes of lipid rich necrotic core and intraplaque hemorrhage and are subsequently 
registered to the corresponding T1-weighted cardiovascular magnetic resonance image of the 
plaque. 
ROI - region of interest. 
 
Figure 2. Base magnetic resonance images for each patient. 
 
For each patient, base images are shown for T1W images, as well as fat, water and R2* maps 
from the Dixon sequence. 
 
Figure 3. Histology of lipid rich necrotic core and intraplaque hemorrhage. 
 
Trichrome stained histological section of carotid plaque showing regions of lipid rich necrotic 
core and intraplaque hemorrhage. The lipid rich necrotic core was identified as amorphous 
material containing cholesterol crystals and intraplaque hemorrhage was identified as contiguous 
areas containing red blood cells as visualized by the trichrome stain. 
 
Figure 4. Registration of 3D histology and the corresponding T1-weighted magnetic resonance 
image.  
 
(A) The 3D histology volumes and MRI data from patient no. 1 are shown. The upper panels 
show non-zoomed T1-weighted base images in the X, Y and Z direction. The fields of view for 
the zoom-ins are shown in red. The letters on the panels indicate the orientation of the images: A 
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= anterior, H = head, R = right. The middle panels show zoomed T1W of the carotid artery lower 
panels in the X, Y and Z direction. The lower panels show the same images with the mask from 
3D histology superimposed. The 3D histology and MRI volumes were manually registered in 
MeVisLab 2.2.1. (MeVis Medical Solutions AG, Bremen, Germany) by matching the lumen in 
the 3D histology volume with the lumen in the MRI. The scaling factors applied in all five 
patients during this registration to account for tissue shrinkage ex-vivo are shown in Supporting 
Table 1. (B) Range of angles showing the deviation from the vertical axis of the internal carotid 
artery in all patients as visualized from the T1-weighted image. The lines deviating from the 
vertical axis indicate the path of blood flow through the internal carotid artery. 
A – anterior; H- head; R – right. 
 
Figure 5. Histology section, T1-weighted image and corresponding fat and R2* maps showing 
clear separation of the fat fraction and R2* signal as well as limitations of registration of 2D 
histology with 2D magnetic resonance imaging slices. 
 
Histology section and magnetic resonance imaging data showing the atherosclerotic plaque from 
patient no. 1. From left to right the panels show the histology section, the T1-weighted image, 
and the corresponding fat and R2* maps of the atherosclerotic plaque (a-d). The plaque was 
segmented in the T1W MRI after registration with 3D histology. The lower panels show the 
corresponding base MR images (e-g). The fields of view for the zoom-ins are shown in red. 
There is a clear separation of the highest fat fraction (white in (c) from the highest R2* value 
(white in (d). The area of lipid rich necrotic core from histology is indicated by the yellow line 
superimposed on panel (c) and the area of intraplaque hemorrhage is indicated by the red line 
superimposed on panel (d). In this patient the atherosclerotic plaque was at a 13.42° angle to the 
vertical plane (see Fig. 4B) resulting in a displacement error causing partial mismatch between 
2D histology and 2D MRI as shown in the figure. An angulation error of 7° results in a 
displacement error of 0.6 mm (1 voxel) at a distance of 5 mm, thus here this error amounted to 
almost two voxels at 5 mm (12). 
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Figure 6. Average fat fractions and R2* values in- and outside lipid rich necrotic core and 
intraplaque hemorrhage. 
 
Average fat fraction from Dixon imaging within regions of lipid rich necrotic core (labeled “In”) 
as identified by 3D histology versus the average fat fraction in the rest of the plaque (labeled 
“Out”) (a-e) and average R2* value from Dixon imaging within regions of intraplaque 
hemorrhage as identified by 3D histology versus the average R2* value in the rest of the plaque 
(f-j). 
IPH – intraplaque haemorrhage; LRNC – lipid rich necrotic core; *** P < 0.001. 
 
Figure 7. Correlation of cumulative fat fractions and R2* values with 3D histology. 
 
The first column on the left shows visualization of the combined fat and R2* signal from Dixon 
imaging (a, e, i, m, q), where all masked tissue was depicted in 3D as transparent grey. The fat 
values were superimposed with a yellow linear color ramp using a threshold of 5%. The R2* 
values were superimposed with a red linear color ramp using a threshold of 50s-1. The red arrows 
show the orientation of the internal carotid artery from which the plaque was retrieved. The next 
column directly to the right shows 3D histology volume renderings of the atherosclerotic plaque 
(b, f, j, n, r). The orientation is identical to the internal carotid artery visualized from magnetic 
resonance imaging. The lipid rich necrotic core volume is indicated in yellow and the intraplaque 
hemorrhage volume is indicated in red. The next two columns show correlation plots of the 
cumulative fat fraction (c, g, k, o, s) and the cumulative R2* value (d, h, l, p, t) within the plaque 
from the Dixon sequence against the volume of the lipid rich necrotic core and intraplaque 
hemorrhage from 3D histology. 
IPH – intraplaque hemorrhage; LRNC – lipid rich necrotic core. 
 
Figure 8. Bland-Altman plots showing the mean difference and the 95% limits of agreement 
between magnetic resonance imaging and 3D histology. 
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Bland-Altman plots showing the mean difference and 95% limits of agreement for the two 
methods. The upper row (a-e) shows the mean difference and 95% limits of agreement for 
cumulative fat fraction from Dixon imaging and the volume of lipid rich necrotic core from 3D 
histology. The lower row shows the same for the cumulative R2* value and the volume of 
intraplaque hemorrhage (f-j). As is apparent from Figure 7, the difference between the methods 
increases as the magnitude of the measured values increases. As recommended by Bland and 
Altman, this approximate proportionality between difference and magnitude of the 
measurements was addressed by plotting the ratio of the MRI values versus the 3D histology 
values as a function of their average (21).  
IPH – intraplaque hemorrhage; LRNC – lipid rich necrotic core. 
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SUPPORTING INFORMATION 
Supporting Table 1. Scaling Factors Applied upon Registration of 3D Histology with Magnetic 
Resonance Imaging. 
  X  Y  Z 
Patient 1  0.021  0.021  0.06 
Patient 2  0.021  0.021  0.06 
Patient 3  0.021  0.021  0.06 
Patient 4  0.0207  0.0207  0.06 
Patient 5  0.0203  0.0203  0.06 
 
The 3D histology volumes and MRI data were manually registered in MeVisLab 2.2.1. (MeVis Medical 
Solutions AG, Bremen, Germany) by matching the lumen in the 3D histology volume with the lumen in the 
MRI. The table shows the scaling factors applied in all five patients during this registration to account for tissue 
shrinkage ex-vivo. 
 
